1-8 of 8
Wenjun Wu, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Incidence and Risk Factors Associated with Infection after Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory B-Cell Malignancies

Feng Zhu, Yongxian Hu, MD, Wei Guoqing, He Huang, Wenjun Wu, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3220.
https://doi.org/10.1182/blood-2019-129649
Published: 2019
Journal Articles

Quantification of Non-Hodgkin Lymphoma Disease Burden Using FDG PET-CT Helps Predict the Severity of Cytokine Release Syndrome

Jiasheng Wang, MD, Yongxian Hu, MD PhD, Yanlei Zhang, Guoqing Wei, MD, Huijun Xu, Wenjun Wu, MD, Shaohui Liu, Kangyan Wang, Zhenxing Guo, Alex Hongsheng Chang, Kui Zhao, He Huang, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2997.
https://doi.org/10.1182/blood-2018-99-117983
Published: 2018
Journal Articles

Chimeric Antigen Receptor T-Cell Therapy Shapes T Cell Repertoire in Chinese Patients with B-Cell Acute Lymphocyte Leukemia

Xiujian Wang, Tao Sun, PhD, Yongxian Hu, MD PhD, Xiao Liu, PhD, Jian Yu, MD, Pengfei Xu, Guoqing Wei, MD, Chao Jin, Wenjun Wu, MD, Fu Huarui, MD, Lijuan Ding, Fang Ni, Hao Zhang, Zuyu Liang, Binsheng Wang, PhD, Xiaoqing Li, Cong Wei, Yunyun Deng, MS, Jimin Shi, MD, Lei Xiao, PhD, Zhao Wu, PhD, He Huang, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1413.
https://doi.org/10.1182/blood-2018-99-115780
Published: 2018
Journal Articles

Comparison of Chimeric Antigen Receptor T Cells from Allogenic or Autologous Sources in Patients with Acute Lymphoblastic Leukemia

Yongxian Hu, MD PhD, Jiasheng Wang, MD, Yanlei Zhang, Guoqing Wei, MD, Huijun Xu, Wenjun Wu, MD, Jian Yu, MD, Yi Luo, MD, Jimin Shi, MD, Shaohui Liu, Kangyan Wang, Zhenxing Guo, Alex HONGSHENG Chang, He Huang, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2691.
https://doi.org/10.1182/blood-2018-99-117910
Published: 2018
Journal Articles

Interference of HMGB1 Lead to Increased Vulnerability of MM Cells to Dexamethasone and Doxorubicin

Xing Guo, M.MD, Donghua He, PhD, Jing Chen, M.MD, Xuanru Lin, M.MD, Qingxiao Chen, M.MD, Haimeng Yan, Xi Huang, M.MD, Yi Li, PhD, Li Yang, PhD, Enfan Zhang, M.MD, Yang Yang, PhD, Wenjun Wu, MD, Jingsong He, He Huang, MD PhD, Zhen Cai, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2086.
https://doi.org/10.1182/blood.V128.22.2086.2086
Published: 2016
Journal Articles

TET2 Downregulation Leads to AML Cells Sensitive to Decitabine

Qingxiao Chen, M.MD, Jingsong He, PhD, Xing Guo, M.MD, Jing Chen, M.MD, Li Yang, PhD, Xuanru Lin, M.MD, Yi Li, PhD, Enfan Zhang, M.MD, Yang Yang, PhD, Wenjun Wu, MD, Donghua He, PhD, He Huang, MD PhD, Shizhou Liu, MD PhD, Zhen Cai, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3643.
https://doi.org/10.1182/blood.V126.23.3643.3643
Published: 2015
Journal Articles

Quercetin Displays Anti-Myeloma Activity and Synergistic Effect with Dexamethasone in Vitro and In Vivo Xenograft Models

Xing Guo, M.MD, Donghua He, PhD, Li Yang, PhD, Yi Li, PhD, Qingxiao Chen, M.MD, Jing Chen, M.MD, Enfan Zhang, M.MD, Xuanru Lin, M.MD, Jingsong He, PhD, Yang Yang, PhD, Xiaoyan Han, MD, Gaofeng Zheng, MD, Wenjun Wu, MD, Yi Zhao, PhD, He Huang, MD PhD, Zhen Cai, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5339.
https://doi.org/10.1182/blood.V126.23.5339.5339
Published: 2015
Journal Articles

Efficacy and Safety of Bortezomib Based Regimens Retreatment in Relapsed Multiple Myeloma Patients: Results from a Retrospective Study.

Wenjun Wu, MD, Gaofeng Zheng, MD, Xiaoyan Han, MD, Yi Zhao, PhD, Donghua He, PhD, Yang Yang, PhD, Jingsong He, PhD, Weiyan Zheng, Jie Sun, MD PhD, Jimin Shi, Guoqing Wei, MD PhD, He Huang, MD PhD, Zhen Cai
Journal: Blood
Blood (2015) 126 (23): 5387.
https://doi.org/10.1182/blood.V126.23.5387.5387
Published: 2015